Rafarma Pharmaceuticals

Rafarma Pharmaceuticals is a company listed under the stock ticker RAFA (US).

View the org chart displaying its 2 main executives

Most searched biographies at Rafarma Pharmaceuticals

• Vladimir Dolgolenko, Chief Executive Officer and President
• Ilia Shpurov, Chairman of the Board

Create your alert
to follow the executive moves at Rafarma Pharmaceuticals.

Rafarma Pharmaceuticals has 1,860 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma
• Emma Walmsley - Chief Executive Officer and Director at GSK

Learn more about the Pharmaceuticals industry >

Press releases by Rafarma Pharmaceuticals

Social media about Rafarma Pharmaceuticals

• Rafarma Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Rafarma Pharmaceuticals on LinkedIn, Twitter & YouTube

Call Rafarma Pharmaceuticals at +1 307...

View the org chart

Register to receive your alert

Report an error